GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
GRAL(NASDAQ:GRAL) MENLO PARK, Calif., Sept. 10, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual...
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAL(NASDAQ:GRAL) MENLO PARK, Calif., Aug. 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of...
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
GRALMENLO PARK, Calif., Aug. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday,...
Shake Shack, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
GRALCanaccord Genuity Maintains Buy on GRAIL, Raises Price Target to $43
GRALGRAIL Q1 EPS $(3.10) Beats $(4.11) Estimate, Sales $31.84M Miss $35.20M Estimate
GRALGRAIL Partners With athenahealth To Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri Multi-Cancer Early Detection Test
GRALGRAIL To Present New Data On Galleri MCED Test And Additional Data From GRAIL's ctDNA-based Targeted Methylation Platform At AACR Annual Meeting In Chicago
GRALCanaccord Genuity Initiates Coverage On GRAIL with Buy Rating, Announces Price Target of $32
GRALMorgan Stanley Maintains Equal-Weight on GRAIL, Raises Price Target to $20
GRALGRAIL Q4 EPS $(2.89) Up From $(6.04) YoY, Sales $38.25M Up From $30.33M YoY
GRALReported Earlier, GRAIL's Galleri Test Outcomes Published In Lancet Oncology, Showing Minimal Distress In Early Cancer Detection
GRALGRAIL 13G Filing Shows Sessa Capital (Master), L.P. Reported A 9.66% Stake In The Co As Of September 30, 2024
GRALCNBC's Final Trades: Volkswagen, Illumina, Goldman Sachs And This Mobility Play
GRALOn CNBC’s “Halftime Report Final Trades,” Stephen Weiss of Short Hills Capital Partners said that Volkswagen AG (OTC: VWAPY) is the “most compelling stock there is.&r
